The current HUGE market cap is 5.71M. The company's latest EPS is USD -0.2820 and P/E is -0.32.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.38M | -5.5M | -10.02M | -2.25M | -3.47M |
Net Income | -5.49M | -1.06M | -1.39M | -1.9M | -3.11M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 257k | 15k | 0 | 0 | 0 |
Operating Income | -29.86M | -28.77M | -20.23M | -13.72M | -24.13M |
Net Income | -52.01M | -31.8M | -35.29M | -23.61M | -17.9M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 21.41M | 18.94M | 17.47M | 15.44M | 15.25M |
Total Liabilities | 5.86M | 4.2M | 4.57M | 3.92M | 5.05M |
Total Equity | 15.55M | 14.75M | 12.91M | 11.52M | 10.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 57.45M | 41.97M | 62.96M | 38.41M | 17.47M |
Total Liabilities | 9.23M | 5.66M | 8.83M | 7.87M | 4.57M |
Total Equity | 48.22M | 36.31M | 54.13M | 30.54M | 12.91M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.26M | -9.98M | -10.83M | -1.97M | -2.58M |
Investing | N/A | -270k | -270k | -22k | 716k |
Financing | -3.05M | -3.1M | -3.13M | 568k | 2.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.23M | -19.13M | -20.75M | -28.33M | -10.83M |
Investing | -307k | 6.52M | 269k | 12.12M | -270k |
Financing | 5.33M | 24.17M | 38.21M | -2.07M | -3.13M |
Market Cap | 5.71M |
Price to Earnings Ratio | -0.32 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.07 |
Price to Book Ratio | 0.44 |
Dividend Yield | - |
Shares Outstanding | 63.49M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0.65%) |
Company Name | FSD Pharma Inc |
Address |
199 bay street, suite 4000 toronto, ontario M5L 1A9 |
Website | https://www.fsdpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.